Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Jun 30, 2023 3:40pm
144 Views
Post# 35522857

RE:RE:RE:Do we know who has been selling these last few days?

RE:RE:RE:Do we know who has been selling these last few days?I don't think they are the only ones, but someone was making a move before the quarter-end.  I'm trying hard to be patient, but it's getting more and more difficult to do considering the elongated timelines, constant set backs, and a company that's running out of time to avoid fairly significant consequences.  I've lost in excess of $200K on this stock.  I'm sure many of you have lost more or at least seen your profits pulled back significantly.  I really, really wish the company would be more clear on exactly what they would need to do to hit their financial objectives they layed out "to be cash flow positive by FYE."  While they've demonstrated a serious willingness to put huge risk on the table and hold out, even coming down to the bare minimum on cash needs, I don't get a sense that management has what it takes to do what it takes when the time comes.  They've put shareholders in quite a quandry.  But, I'm not making any decisions until I see the TH-1902 outcome through.  Lose it all or win big.  I'm here for it!  I used to love the odds of THTX.  Now I hate them.  A breakeven will be a win at this point.  Nothing new to express here.  Just super frustrated.

If I ran this company and the stock was where it is today, I would have weekly podcast updates on the website for investors, employees, and customers to listen to.  I'd get ridiculously granular.  I'd share details on data from sales efforts (number of calls, conversion ratios, number of new prescribers compared to existing, etc.), discuss progress on pipeline assets (even if that means saying there has been none, but provide extreme clarity on anything that can be publicaly acknowleged and explain what can't be discussed due to the need to be discreet), along with any other topic that engages investors.  I would repeat the value proposition, over and over again.  I'd sound like a broken record and give my personal cell phone to the public.  I've seen multiple bank CEO's do that during the banking contagion.  They weren't hiding, and they understood the importance of maintaining the faith of investors, customers, and employees.
<< Previous
Bullboard Posts
Next >>